Date: November 13th to 15th, 2024
Format: Onsite Congress
Venue: Palacio de Congresos de Zaragoza. Plaza Lucas Miret Rodriguez, 1, 50018, Zaragoza
Juan Carlos López Gil
Rafael López López
Alberto J. Schuhmacher
OPENING LECTURE | KEYNOTE
In the world of cancer immunotherapy, Antoni Ribas, MD, PhD, has earned a reputation for being both a world-class scientist and a devoted physician. As a tumor immunologist at UCLA’s Jonsson Comprehensive Cancer Center, Dr. Ribas specializes in the research and treatment of melanoma, the deadliest form of skin cancer. He is conducting several large clinical trials of cutting-edge treatments, including both immunotherapies and targeted therapies.
Dr. Ribas is a member of the Cancer Research Institute (CRI) clinical trials network, as well as the CRI/Stand Up to Cancer “Dream Team.
CLOSING LECTURE | KEYNOTE
JOHANN S. DE BONO
Professor Johann de Bono is the Head of the Division of Clinical Studies and an international expert in the development of novel anticancer therapies against adult cancers. His team of runs one of the world’s largest phase I clinical trials units for cancer, with >100 staff including dedicated radiology and pathology staff; he also runs a separate team focused on improving prostate cancer care that have led pivotal phase III trials of several prostate cancer drugs including abiraterone, cabazitaxel, enzalutamide and olaparib as well more recently ipatasertib and lutetium-PSMA.